Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
J Health Commun ; 29(2): 119-130, 2024 02.
Artigo em Inglês | MEDLINE | ID: mdl-38131342

RESUMO

The National Cancer Institute's (NCI) Health Information National Trends Survey (HINTS) is a nationally representative survey of U.S. adults in which 12-17% of respondents report a cancer history. To increase representation from adult cancer survivors, in 2021, NCI sampled survivors from three Surveillance, Epidemiology, and End Results (SEER) program cancer registries: Iowa, New Mexico, and the Greater Bay Area. Sampling frames were stratified by time since diagnosis and race/ethnicity, with nonmalignant tumors and non-melanoma skin cancers excluded. Participants completed a self-administered postal questionnaire. The overall response rate for HINTS-SEER (N = 1,234) was 12.6%; a non-response bias analysis indicated few demographic differences between respondents and the pool of sampled patients in each registry. Most of the sample was 10+ years since diagnosis (n = 722; 60.2%); 392 respondents were 5 to < 10 years since diagnosis (29.6%); and 120 were < 5 years since diagnosis (10.2%). Common cancers included male reproductive (n = 304; 24.6%), female breast (n = 284; 23.0%), melanoma (n = 119; 9.6%), and gastrointestinal (n = 106; 8.6%). Tumors were mostly localized (67.8%; n = 833), with 22.4% (n = 282) regional, 6.2% (n = 72) distant, and 3.7% (n = 47) unknown. HINTS-SEER data are available by request and may be used for secondary analyses to examine a range of social, behavioral, and healthcare outcomes among cancer survivors.


Assuntos
Sobreviventes de Câncer , Neoplasias , Adulto , Estados Unidos/epidemiologia , Humanos , Masculino , Feminino , Projetos Piloto , National Cancer Institute (U.S.) , Neoplasias/terapia , Sistema de Registros , Inquéritos e Questionários , Incidência
2.
Pharmacoepidemiol Drug Saf ; 32(3): 312-320, 2023 03.
Artigo em Inglês | MEDLINE | ID: mdl-35864719

RESUMO

PURPOSE: FDA regulations state print ads for prescription drugs must provide a true statement of information "in brief summary" describing "side effects, contraindications and effectiveness." To fulfill these requirements, these ads typically display risk information both as important safety information (ISI) on the "main" ad page with the product claims and on a separate "brief summary" page. The ISI can be lengthy and may repeat brief summary content. METHODS: The authors tested two versions of the ISI (short versus long) and the presence or absence of a brief summary in direct-to-consumer prescription drug print ads for two medical conditions: overactive bladder (N = 181) and rheumatoid arthritis (N = 179). Attention was measured with eye-tracking and self-report methods. Risk retention and perceptions were self-reported. RESULTS: Participants spent more time viewing ads with a long ISI or a brief summary and in some instances, recalled more risks. The combination of a long ISI and a brief summary did not increase or decrease attention to or retention of risk information. CONCLUSION: A long ISI and a brief summary may perform similar functions.


Assuntos
Medicamentos sob Prescrição , Humanos , Medicamentos sob Prescrição/efeitos adversos , Publicidade/métodos , Tecnologia de Rastreamento Ocular , Rememoração Mental
3.
Nicotine Tob Res ; 21(11): 1565-1572, 2019 10 26.
Artigo em Inglês | MEDLINE | ID: mdl-30239948

RESUMO

INTRODUCTION: Emerging tobacco products have become increasingly popular, and the US Food and Drug Administration extended its authority to all products meeting the definition of a tobacco product in 2016. These changes may lead to shifts in public perceptions about tobacco products and regulation, and national surveys are attempting to assess these perceptions at the population level. This article describes the item development and cognitive interviewing of the tobacco product and regulation perception items included in two tobacco-focused cycles of the Health Information National Trends Survey (HINTS-FDA), referred to as HINTS-FDA. METHODS: Cognitive interviewing was used to investigate how respondents comprehended and responded to tobacco product and regulation perception items. Adult participants (n = 20) were selected purposively to oversample current tobacco users and were interviewed in two iterative rounds. Weighted descriptive statistics from the fielded HINTS-FDA surveys (N = 5474) were also calculated. RESULTS: Items were generally interpreted as intended, and participants meaningfully discriminated between tobacco products when assessing addiction perceptions. Response selection issues involved inconsistent reporting among participants with little knowledge or ambivalent opinions about either government regulation or tobacco products and ingredients, which resolved when a "don't know" response option was included in the survey. The fielded survey found that a non-negligible proportion of the population do not have clear perceptions of emerging tobacco products or government regulation. CONCLUSIONS: A "don't know" response option is helpful for items assessing many emerging tobacco products but presents several analytic challenges that should be carefully considered. Multiple items assessing specific tobacco product and regulation perception items are warranted in future surveys. IMPLICATIONS: The findings from this study can serve as a foundation for future surveys that assess constructs related to emerging tobacco products, harm perceptions across multiple tobacco products, and tobacco-related government regulatory activities. The data provide unique insight into item-specific motivation for selecting a "don't know" response option for tobacco survey items.


Assuntos
Conhecimentos, Atitudes e Prática em Saúde , Inquéritos e Questionários , Produtos do Tabaco/legislação & jurisprudência , Tabagismo/prevenção & controle , Regulamentação Governamental , Humanos , Estados Unidos
4.
J Health Commun ; 21(12): 1269-1275, 2016 12.
Artigo em Inglês | MEDLINE | ID: mdl-27892827

RESUMO

The National Cancer Institute (NCI) developed the Health Information National Trends Survey (HINTS) to monitor population trends in cancer communication practices, information preferences, health risk behaviors, attitudes, and cancer knowledge. The U.S. Food and Drug Administration (FDA) recognized HINTS as a unique data resource for informing its health communication endeavors and partnered with NCI to field HINTS-FDA 2015. HINTS-FDA 2015 was a self-administered paper instrument sent by mail May 29 to September 8, 2015, using a random probability-based sample of U.S. postal addresses stratified by county-level smoking rates, with an oversampling of high and medium-high smoking strata to increase the yield of current smokers responding to the survey. The response rate for HINTS-FDA 2015 was 33% (N = 3,738). The yield of current smokers (n = 495) was lower than expected, but the sampling strategy achieved the goal of obtaining more former smokers (n = 1,132). Public-use HINTS-FDA 2015 data and supporting documentation have been available for download and secondary data analyses since June 2016 at http://hints.cancer.gov . NCI and FDA encourage the use of HINTS-FDA for health communication research and practice related to tobacco-related communications, public knowledge, and behaviors as well as beliefs and actions related to medical products and dietary supplements.


Assuntos
Comunicação em Saúde/tendências , Inquéritos Epidemiológicos , Serviços de Informação/tendências , National Cancer Institute (U.S.) , Neoplasias , Adolescente , Adulto , Idoso , Feminino , Comportamentos Relacionados com a Saúde , Conhecimentos, Atitudes e Prática em Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias/psicologia , Preferência do Paciente , Assunção de Riscos , Fumar/epidemiologia , Estados Unidos/epidemiologia , United States Food and Drug Administration , Adulto Jovem
5.
PLoS One ; 17(11): e0269110, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36322570

RESUMO

Address based sampling (ABS) has become current state-of-the-art methodology for conducting household surveys by mail, telephone or web in the United States. One potential advantage of ABS frames is that additional information about the sampled households can be appended and leveraged for data collection and analytic purposes. The appended data come from many sources and are of variable quality and completeness. The goals of this research were to evaluate data quality of demographic and socioeconomic variables provided for recent ABS samples from one vendor, and to examine their potential usefulness for sample design, including oversampling. We report on the completeness of the appended data as well as their concordance with data reported by respondents to two recent large ABS household surveys, one that invited households to complete the survey online and another that was mail only. Based on the quality assessment, we also examine the utility of the appended variables for oversampling. Our general conclusions are that the quality of select appended variables has improved such that the Hispanic origin, Hispanic surname, and presence of age group 65+ variables may be used to efficiently oversample these subgroups. However, this is not the case for oversampling other subgroups through appended variables for home tenure; those with head of household whose educational attainment is high school or less; low income households; households with children; presence of age groups 18-24, 25-34, and 35-64; or households based on the number of adults in the household.


Assuntos
Confiabilidade dos Dados , Características da Família , Inquéritos e Questionários , Humanos , Internet , Serviços Postais , Fatores Socioeconômicos , Estados Unidos , Criança , Adolescente , Adulto Jovem , Adulto , Pessoa de Meia-Idade , Idoso
6.
Artigo em Inglês | MEDLINE | ID: mdl-35682402

RESUMO

Workplace safety is critical for advancing patient safety and eliminating harm to both the healthcare workforce and patients. The purpose of this study was to develop and test survey items that can be used in conjunction with the Agency for Healthcare Research and Quality (AHRQ) Surveys on Patient Safety Culture™ (SOPS®) Hospital Survey to assess how the organizational culture in hospitals supports workplace safety for providers and staff. After conducting a literature review and background interviews with workplace safety experts, we identified key areas of workplace safety culture (workplace hazards, moving/transferring/lifting patients, workplace aggression, supervisor/management support for workplace safety, workplace safety reporting, and work stress/burnout) and drafted survey items to assess these areas. Survey items were cognitively tested and pilot tested with the SOPS Hospital Survey 2.0 among providers and staff in 28 U.S. hospitals. We conducted psychometric analysis on data from 6684 respondents. Confirmatory factor analysis results (item factor loadings and model fit indices), internal consistency reliability, and site-level reliability were acceptable for the 16 survey items grouped into 6 composite measures. Most composite measures were significantly correlated with each other and with the overall rating on workplace safety, demonstrating conceptual convergence among survey measures. Hospitals and researchers can use the Workplace Safety Supplemental items to assess the dimensions of organizational culture that support provider and staff safety and to identify both strengths and areas for improvement.


Assuntos
Segurança do Paciente , Local de Trabalho , Hospitais , Humanos , Cultura Organizacional , Projetos Piloto , Psicometria , Reprodutibilidade dos Testes , Gestão da Segurança , Inquéritos e Questionários
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA